Childrens Hospital of Colorado

Aurora, Colorado 88045

19 studies enrolling now · 82 studies all time

What they study most

Abnormal Glucose Tolerance, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Adenovirus, Atrioventricular Septal Defect, Autism Spectrum Disorder, Autosomal Recessive Hypophosphatemic Rickets, B-ALL, Bacteremia, Bone Cancer, Brain Diseases

Studies at this site

• A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma — Recruiting now
• A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy — Recruiting now
• Streamlined Treatment of Pulmonary Exacerbations in Pediatrics — Recruiting now
• COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction — Recruiting now
• Clinical and Basic Investigations Into Congenital Disorders of Glycosylation — Recruiting now
• A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy — Recruiting now
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. — Recruiting now
• Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy — Recruiting now
• Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease — Recruiting now
• Gastroschisis Outcomes of Delivery (GOOD) Study — Recruiting now
• GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance — Recruiting now
• Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age — Recruiting now
• North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) — Recruiting now
• A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors — Recruiting now
• Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection — Recruiting now
• Pediatric Post-Approval Registry — Recruiting now
• Feasibility of Cough Monitoring in Children — Recruiting now
• Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis — Completed
• Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma — Running, not enrolling
• Technology-assisted Language Intervention (TALI) — Completed
• The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain — Completed
• Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• A Phase 2b Study of Zagociguat in Patients With MELAS — Completed
• An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM) — Running, not enrolling
• Cerliponase Alfa Observational Study in the US — Running, not enrolling
• Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program — Running, not enrolling
• Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG — Running, not enrolling
• Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age — Running, not enrolling
• X-linked Hypophosphatemia Disease Monitoring Program — Running, not enrolling
• GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study — Completed
• Trial of Reducing Inpatient Antibiotic Durations in Children — Enrolling by invitation
• Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants — Running, not enrolling
• Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children — Running, not enrolling
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older — Completed
• A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study — Enrolling by invitation
• COMPASSION S3 Post-Approval Study — Running, not enrolling
• Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) — Running, not enrolling
• Improving Outcomes Using Technology for Children Who Are DHH — Running, not enrolling
• Evolutionary Therapy for Rhabdomyosarcoma — Running, not enrolling
• Study of MEK162 for Children With Low-Grade Gliomas — Completed
• Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML — Stopped early
• Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas — APPROVED_FOR_MARKETING
• Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia — Running, not enrolling
• The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency — Running, not enrolling
• Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis — Completed
• TK216 in Patients With Relapsed or Refractory Ewing Sarcoma — Stopped early
• HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve — Completed
• Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study — Completed
• A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment — Completed